First, among H/L CRC patients treated with FOLFOX, preliminary AI analysis indicated a potential association between TGF-β pathway alterations and reduced overall survival, which was confirmed by subsequent Kaplan–Meier analysis. Here, TGFB1 is linked to colorectal carcinoma.